FDA’s Allowable Level of Aluminum in Vaccines Based on Decades-Old Tests — but the Tests Had Nothing to Do With Safety

A new review of studies underpinning the FDA’s limit on the allowable level of aluminum adjuvant per vaccine dose reveals the level, set decades ago, was determined on the basis of how well the adjuvant generated an immune response — not on whether the aluminum posed a health risk.